Sonoma Pharmaceuticals, Inc. (SNOA)
1.32
-0.01
(-0.75%)
USD |
NASDAQ |
Sep 09, 16:00
1.32
0.00 (0.00%)
After-Hours: 16:29
Sonoma Pharmaceuticals Debt to Equity Ratio : 0.1121 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1121 |
| March 31, 2026 | 0.2721 |
| December 31, 2025 | 0.1909 |
| September 30, 2025 | 0.1413 |
| June 30, 2025 | 0.1664 |
| March 31, 2025 | 0.0691 |
| December 31, 2024 | 0.0244 |
| September 30, 2024 | 0.0456 |
| June 30, 2024 | 0.0844 |
| March 31, 2024 | 0.0991 |
| December 31, 2023 | 0.0575 |
| September 30, 2023 | 0.092 |
| June 30, 2023 | 0.0904 |
| March 31, 2023 | 0.1064 |
| December 31, 2022 | 0.0874 |
| September 30, 2022 | 0.1102 |
| June 30, 2022 | 0.1196 |
| March 31, 2022 | 0.1572 |
| December 31, 2021 | 0.1083 |
| September 30, 2021 | 0.1297 |
| June 30, 2021 | 0.5256 |
| March 31, 2021 | 0.4988 |
| December 31, 2020 | 0.1608 |
| September 30, 2020 | 0.1744 |
| June 30, 2020 | 0.1811 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1511 |
| December 31, 2019 | 0.098 |
| September 30, 2019 | 0.1298 |
| June 30, 2019 | 0.1375 |
| March 31, 2019 | 0.0453 |
| December 31, 2018 | 0.0153 |
| September 30, 2018 | 0.0295 |
| June 30, 2018 | 0.0378 |
| March 31, 2018 | 0.0361 |
| December 31, 2017 | 0.0261 |
| September 30, 2017 | 0.0276 |
| June 30, 2017 | 0.0279 |
| March 31, 2017 | 0.0191 |
| December 31, 2016 | 0.0026 |
| September 30, 2016 | 0.0129 |
| June 30, 2016 | 0.0085 |
| March 31, 2016 | 0.0112 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.0031 |
| March 31, 2015 | 0.0072 |
| December 31, 2014 | 0.0008 |
| September 30, 2014 | 0.0006 |
| June 30, 2014 | 0.0048 |
| March 31, 2014 | 0.0122 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 18.11M |
| Total Liabilities (Quarterly) | 11.51M |
| Shareholders Equity (Quarterly) | 6.594M |
| Current Ratio | 2.987 |
| Net Debt Paydown Yield | -1.47% |